Lyphomed Company Profile

What is the competitive landscape for LYPHOMED, and what generic and branded alternatives to LYPHOMED drugs are available?

LYPHOMED has seven approved drugs.

Summary for Lyphomed

US Patents:	0
Tradenames:	7
Ingredients:	7
NDAs:	7

Drugs and US Patents for Lyphomed

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lyphomed	DIPHENHYDRAMINE HYDROCHLORIDE	diphenhydramine hydrochloride	INJECTABLE;INJECTION	087066-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lyphomed	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	018549-001	Mar 11, 1983		DISCN	No	No
Lyphomed	AMINOPHYLLINE	aminophylline	INJECTABLE;INJECTION	087431-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lyphomed	LIDOCAINE HYDROCHLORIDE	lidocaine hydrochloride	INJECTABLE;INJECTION	080390-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Lyphomed	DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	087065-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lyphomed	LIDOCAINE HYDROCHLORIDE	lidocaine hydrochloride	INJECTABLE;INJECTION	080390-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lyphomed	METOCLOPRAMIDE HYDROCHLORIDE	metoclopramide hydrochloride	INJECTABLE;INJECTION	070293-001	Jan 24, 1986		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Lyphomed